RxDoctor Payments Data

Anurag Agarwal, MD

Facial Plastic Surgery · Naples, FLNPI 1972539237

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 71.4% of it on its own, with 12 other manufacturers making up the rest.

$2,095in general payments, 2019–2025

Across 92 payments — averaging $22.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Galderma Laboratories, L.p.$212
  • Alk-abello, Inc$94
  • Mentor Worldwide LLC$64
  • AVEO Pharmaceuticals, Inc.$34
  • Regeneron Healthcare Solutions, Inc.$34
  • plus $163 from 7 others

What the payments were for

  • Food & beverage$2,095100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,095 in reported general payments places this provider in the 55th percentile of 49 facial plastic surgery providers in Florida.

See all facial plastic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$9,007
Medicare patients
13
Services billed
18

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate67$1,324
ValacyclovirValacyclovir Hcl38$430
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen62$401
Dexamethasone55$220
Zolpidem Tartrate50$158
Cephalexin65$150
Promethazine Hcl33$95
Chlorhexidine Gluconate12$45

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Naples

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →